Over 140,000 Bottles of medication are not safe. It’s easy to put a bottle of prescription pills in the medicine cabinet and forget about what’s on the label — until something like a recall jolts you ...
The prescription impacted is Atorvastatin Calcium tablets sold in 90-count, 500-count and 1000-count packages. Contact your healthcare provider or pharmacy for a potential refund or replacement. The U ...
(NEXSTAR) – Over 141,000 bottles of cholesterol medication have been recalled due to “failed dissolution specifications,” suggesting that the drugs did not pass a solubility test, or failed to ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The Food and Drug ...
The FDA has issued a recall for Atorvastatin Calcium Tablets, a generic version of Lipitor, manufactured by Alkem Laboratories, Ltd. (Photo by Tim Boyle/Getty Images) The FDA has issued a recall for ...
The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help with sleep issues. By Nina Agrawal and Maggie Astor The Food and Drug ...
Federal health officials are advising consumers that more than 140,000 bottles of cholesterol medication are being recalled due to "failed dissolution specifications." Several bottle sizes of ...
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...
Ms. Szalavitz is a contributing Opinion writer. Jessica Massarone couldn’t concentrate in primary school: She was too preoccupied with her parents’ struggles with drug addiction. Sometimes, she’d find ...
Neither the FDA nor the manufacturer has released specific guidance on the recalled medications. If a recall involves prescription medication, WebMD advises patients to call their doctor or pharmacist ...
The Food and Drug Administration on Thursday announced the first round of experimental drugs that will receive drastically expedited reviews at the agency, part of an effort to prioritize medicines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback